pharma · Cystic Fibrosis · Multiple Sclerosis · RARE
Ultragenyx UK
Ultragenyx UK Limited
UGenDx is a pharma organization headquartered in NOVATO, CA, GB. It trades on NYSE under ticker RARE. Primary therapeutic focus areas include Cystic Fibrosis, Multiple Sclerosis, Fanconi's Anemia, Hereditary Inclusion Bo
Company details
- Status
- Public
- HQ
- Newcastle upon tyne, NE128RL, GB, NOVATO, CA
- Founded
- 2024
- Employees
- 2
- Programs
- 201
- Drugs
- 168
- Patents
- 23
pallidotomy
Phase 2 · other · Parkinson Disease
pallidotomy for Parkinson Disease is a Phase 2 program (other) at Ultragenyx UK Limited with 1 ClinicalTrials.gov record(s).
Internal code 199/12083
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Ultragenyx UK Limited
- Phase
- Phase 2
- Modality
- other
- Indication
- Parkinson Disease
- Status
- completed
- Trials
- 1